Format

Send to

Choose Destination
Clin Mol Hepatol. 2012 Jun;18(2):109-62. Epub 2012 Jun 26.

KASL Clinical Practice Guidelines: Management of chronic hepatitis B.

Abstract

The guideline on the management of chronic hepatitis B (CHB) was first developed in 2004 and revised in 2007 by the Korean Association for the Study of the Liver (KASL). Since then there have been many developments, including the introduction of new antiviral agents and the publications of many novel research results from both Korea and other countries. In particular, a large amount of knowledge on antiviral resistance--which is a serious issue in Korea--has accumulated, which has led to new strategies being suggested. This prompted the new guideline discussed herein to be developed based on recent evidence and expert opinion.

TARGET POPULATION:

The main targets of this guideline comprise patients who are newly diagnosed with CHB and those who are followed or treated for known CHB. This guideline is also intended to provide guidance for the management of patients under the following special circumstances: malignancy, transplantation, dialysis, coinfection with other viruses, pregnancy, and children.

KEYWORDS:

Chronic hepatitis B; KASL guidelines; Management

PMID:
22893865
PMCID:
PMC3415874
DOI:
10.3350/cmh.2012.18.2.109
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Publishing M2Community Icon for PubMed Central
Loading ...
Support Center